Sep 10, 2021 / 12:00PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Good morning, everyone in the U.S. Good afternoon, everyone in Europe. My name is Matt Sykes. I'm the senior U.S. life sciences tools and diagnostics panels at Goldman Sachs. And today, I have the pleasure of welcoming the management team from Olink here. I've got Jon Heimer, the Chief Executive Officer; and Oskar Hjelm, the Chief Financial Officer. Jon, Oskar, thanks for joining us.
Jon Heimer - Olink Holding AB(publ)-CEO&Director
Good morning, Matt. Nice to be here. Thank you.
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Jon, maybe I'd just let you start out and kind of set the stage first. You just recently reported your second quarter as a public company. Maybe you could reflect on that. And just a brief history on Olink for those that aren't familiar and some of the trends you're seeing in the business and kind of what's driven
Olink Holding AB (publ) at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 10, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers